Featured Research

from universities, journals, and other organizations

Ventricular assist device gives man chance to resume an active life

Date:
April 12, 2010
Source:
University of Utah Health Sciences
Summary:
After receiving only the fourth US implant of a new-generation, Utah-made ventricular assist device, an Idaho man with heart failure is looking forward to resuming an active life following an operation on March 17 at University of Utah Hospital.

After receiving only the fourth U.S. implant of a new-generation, Utah-made ventricular assist (VAD ) device, an Idaho man with heart failure is looking forward to resuming an active life following an operation on March 17 at University of Utah Hospital.

Douglas Wiley, Kuna, Idaho, received the Levacor™ VAD as part of national clinical trial under way at the University and is anxious to give his new VAD a real-world tryout. "I can't wait to get back on my motorcycle," the 44-year-old says.

The clinical trial, which is evaluating how well the new VAD serves as a bridge for people awaiting a heart transplant, is one of several leading-edge treatment options the University's cardiovascular program offers for people suffering from heart disease, according to Craig H. Selzman, M.D., the Utah principal investigator in the trial and a cardiothoracic surgeon with University of Utah Health Care.

"This new-generation VAD represents a potentially important step in giving patients such as Mr. Wiley the chance to regain their strength and vitality while they wait for a heart transplant," Selzman said. "The University of Utah has a long and proud history in the development and use of implanted blood pumps, and with the Levacor™ clinical trial we are expanding our commitment to help those with this devastating disease."

As an academic medical system, University of Utah Health Care offers the full range of options for people with heart disease -- medical treatment, transplantation, and vanguard technologies and trials such as new VADs and even stem cell transplants to help damaged hearts heal themselves.

The Levacor™ VAD was initially developed at and spun-off from the University of Utah and is being commercialized by WorldHeart Corporation, a Salt Lake City-based company. Unlike other VADs, this one uses a fully magnetically suspended rotor to help pump blood, allowing it to operate without bearings or other moving parts that wear out and can damage blood. Potentially, the Levacor™ VAD could last years longer than other blood pumps.

Although the current clinical trial is evaluating the Levacor™ VAD as a bridge to transplant, the device is expected to be evaluated next as an alternative to heart transplant and may one day serve as a bridge to heart recovery, according to Selzman. Under this premise, an VAD designed to be efficient, durable and that is gentle to blood could take over for a failing heart long enough for the muscle to strengthen on its own or through the help of drugs or other therapies such as autologous stem cell transplants.

The University currently is conducting such a stem cell trial, in which a patient's own stem cells are harvested, purified, and then injected into a diseased heart to help grow healthy cells. But the only way many patients' hearts could repair themselves would be through an extended period of rest provided by a long-lasting VAD.

"We're still in the early stages of clinical testing with the Levacor™ VAD, so there's much work ahead of us. But the potential for using this device as a bridge to recovery is there," Selzman said. "This is the kind of technology and medicine that a major academic medical system such as University of Utah Health Care is ideally suited for investigating."

University Hospital is the second center in the country to implant the device into a patient. The first three patients received their implants at INTEGRIS Baptist Medical Center in Oklahoma City earlier this year.


Story Source:

The above story is based on materials provided by University of Utah Health Sciences. Note: Materials may be edited for content and length.


Cite This Page:

University of Utah Health Sciences. "Ventricular assist device gives man chance to resume an active life." ScienceDaily. ScienceDaily, 12 April 2010. <www.sciencedaily.com/releases/2010/04/100408161015.htm>.
University of Utah Health Sciences. (2010, April 12). Ventricular assist device gives man chance to resume an active life. ScienceDaily. Retrieved October 22, 2014 from www.sciencedaily.com/releases/2010/04/100408161015.htm
University of Utah Health Sciences. "Ventricular assist device gives man chance to resume an active life." ScienceDaily. www.sciencedaily.com/releases/2010/04/100408161015.htm (accessed October 22, 2014).

Share This



More Health & Medicine News

Wednesday, October 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

CDC Revamps Ebola Guidelines After Criticism

CDC Revamps Ebola Guidelines After Criticism

Newsy (Oct. 21, 2014) The Centers for Disease Control and Prevention have issued new protocols for healthcare workers interacting with Ebola patients. Video provided by Newsy
Powered by NewsLook.com
WHO: Ebola Vaccine Trials to Start a in January

WHO: Ebola Vaccine Trials to Start a in January

AP (Oct. 21, 2014) Tens of thousands of doses of experimental Ebola vaccines could be available for "real-world" testing in West Africa as soon as January as long as they are deemed safe in soon to start trials, the World Health Organization said Tuesday. (Oct. 21) Video provided by AP
Powered by NewsLook.com
First-Of-Its-Kind Treatment Gives Man Ability To Walk Again

First-Of-Its-Kind Treatment Gives Man Ability To Walk Again

Newsy (Oct. 21, 2014) A medical team has for the first time given a man the ability to walk again after transplanting cells from his brain onto his severed spinal cord. Video provided by Newsy
Powered by NewsLook.com
CDC Issues New Ebola Guidelines for Health Workers

CDC Issues New Ebola Guidelines for Health Workers

Reuters - US Online Video (Oct. 21, 2014) The U.S. Centers for Disease Control and Prevention has set up new guidelines for health workers taking care of patients infected with Ebola. Linda So reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins